» Articles » PMID: 34663062

Association Between Decreased Ovarian Reserve and Poor Oocyte Quality

Overview
Date 2021 Oct 19
PMID 34663062
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To analyze the association between oocyte quality and decreased ovarian reserve (DOR) markers in young women undergoing controlled ovarian stimulation (COS).

Methods: This retrospective study included 49 patients classified as having DOR based on anti-Müllerian hormone (AMH) levels, follicle-stimulating hormone (FSH) levels, or antral follicle counts (AFCs; <10). Images of all obtained oocytes were analyzed, and oocyte quality was classified according to maturity and morphology. The COS protocol utilized gonadotropin (FSH and/or human menopausal gonadotropin [hMG]) doses ranging from 150 to 300 IU/day. The Student's t test or Mann-Whitney test was used to compare the groups. Spearman's coefficients were estimated to verify the correlation between the administered dose of FSH/hMG and the number of mature oocytes. To evaluate the association between patient- and oocyte-related variables, logistic regression models were adjusted.

Results: Women with DOR classified according to FSH level had more immature oocytes (P<0.001). Women with DOR according to AMH had fewer mature oocytes and increased basal FSH levels (P<0.001). Women with DOR according to AFC had an increased risk of abnormally shaped oocytes (P=0.035).

Conclusion: This study showed that DOR based on AMH levels, FSH levels, and AFC was associated with poorer quality oocytes in young women who underwent COS.

Citing Articles

Effects of flaxseed oil supplementation on metaphase II oocyte rates in IVF cycles with decreased ovarian reserve: a randomized controlled trial.

Chu Q, Yu Y, Zhang J, Zhang Y, Yu J Front Endocrinol (Lausanne). 2024; 15:1280760.

PMID: 38469148 PMC: 10925664. DOI: 10.3389/fendo.2024.1280760.


Sequential embryo transfer combined with intrauterine perfusion improved pregnancy outcomes in patients with recurrent implantation failure.

Zou W, Liu D, Peng J, Tang Z, Li Y, Zhang J BMC Womens Health. 2024; 24(1):126.

PMID: 38365686 PMC: 10873986. DOI: 10.1186/s12905-024-02966-8.


Prevalence and confounders of chronic endometritis diagnosed using CD138 in patients with recurrent implantation failure.

Hue H, Choi H, Lee H, Lee J, Jee B, Choo C Clin Exp Reprod Med. 2024; 51(2):163-169.

PMID: 38263588 PMC: 11140256. DOI: 10.5653/cerm.2023.06170.


The Relationship Between Serum Anti-Müllerian Hormone and Basal Antral Follicle Count in Infertile Women Under 35 Years: An Assessment of Ovarian Reserve.

Islam U, Begum A, Rahman F, Haq M, Kumar S, Chowdhury K Cureus. 2023; 15(12):e50181.

PMID: 38077683 PMC: 10706210. DOI: 10.7759/cureus.50181.


Association of recurrent implantation failure and recurrent pregnancy loss with peripheral blood natural killer cells and interferon-gamma level.

Zargar M, Ghafourian M, Behrahi F, Nikbakht R, Salehi A Obstet Gynecol Sci. 2023; 67(1):112-119.

PMID: 37986570 PMC: 10792307. DOI: 10.5468/ogs.23120.


References
1.
. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014; 101(3):633-4. DOI: 10.1016/j.fertnstert.2013.12.032. View

2.
Fleming R, Seifer D, Frattarelli J, Ruman J . Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod Biomed Online. 2015; 31(4):486-96. DOI: 10.1016/j.rbmo.2015.06.015. View

3.
. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015; 103(3):e9-e17. DOI: 10.1016/j.fertnstert.2014.12.093. View

4.
Katz-Jaffe M, Surrey E, Minjarez D, Gustofson R, Stevens J, Schoolcraft W . Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstet Gynecol. 2012; 121(1):71-7. DOI: 10.1097/aog.0b013e318278eeda. View

5.
Wallace W, Kelsey T . Human ovarian reserve from conception to the menopause. PLoS One. 2010; 5(1):e8772. PMC: 2811725. DOI: 10.1371/journal.pone.0008772. View